Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Trial N9741
- Citation:
- J Clin Oncol vol 28 (20) 3227-3233
- Year:
- 2010
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U01 GM063340, CA-37404, N01 CA032102, U10 CA077202, U10 CA021115, U10 CA037404, CA-25224, U01-GM63340, U10 CA035101, CA-32102, U10 CA032102, N01 CA038926, U10 CA038926, R21 CA102461, CA-77202, CA-21115, CA-35101, U10 CA025224, CA-38926, R21-CA102461
- Corr. Author:
- Authors:
- Howard L. McLeod Daniel J. Sargent Sharon Marsh Erin M. Green Cristi R. King Charles S. Fuchs Ramesh K. Ramanathan Stephen K. Williamson Brian P. Findlay Stephen N. Thibodeau Axel Grothey Roscoe F. Morton Richard M. Goldberg
- Networks:
- Study
- NCCTG-N9741
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Gic5, Faze, To2, To9, To15, Original Reports, Gastrointestinal Cancer